Role of proteinase-activated receptor-2 in anti-bacterial and immunomodulatory effects of interferon-γ on human neutrophils and monocytes

Immunology

Volumn 133, Issue 3, 2011, Pages 329-339

  Shpacovitch, Victoria M ^a,b   Feld, Micha ^a   Holzinger, Dirk ^a   Kido, Makiko ^a,c   Hollenberg, Morley D ^d   Levi Schaffer, Francesca ^e   Vergnolle, Nathalie ^f   Ludwig, Stephan ^a   Roth, Johannes ^a   Luger, Thomas ^a   Steinhoff, Martin ^a,g  

^a UNIVERSITY OF MÜNSTER   (Germany)

^b OTTO VON GUERICKE UNIVERSITY   (Germany)

^c KYUSHU UNIVERSITY   (Japan)

^d UNIVERSITY OF CALGARY   (Canada)

^e HEBREW UNIVERSITY OF JERUSALEM   (Israel)

^f INSERM   (France)

^g UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Innate immunity; Monocyte chemoattractant protein 1; Phagocytosis; Proteinase activated receptor; Staphylococcus aureus

Indexed keywords

GAMMA INTERFERON; JANUS KINASE; MONOCYTE CHEMOTACTIC PROTEIN 1; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEINASE ACTIVATED RECEPTOR 2;

ARTICLE; BACTERICIDAL ACTIVITY; CONTROLLED STUDY; ESCHERICHIA COLI; HUMAN; HUMAN CELL; IMMUNOCOMPETENT CELL; IMMUNOMODULATION; INFLAMMATION; INNATE IMMUNITY; MONOCYTE; NEUTROPHIL; PHAGOCYTOSIS; PRIORITY JOURNAL; PROTEIN SECRETION; RECEPTOR UPREGULATION; STAPHYLOCOCCUS AUREUS;

ANTI-BACTERIAL AGENTS; CELLS, CULTURED; CHEMOKINE CCL2; ESCHERICHIA COLI; HUMANS; IMMUNOLOGIC FACTORS; INTERFERON-GAMMA; MONOCYTES; NEUTROPHILS; RECEPTOR, PAR-2; RECOMBINANT PROTEINS; STAPHYLOCOCCUS AUREUS;

EID: 79957838438     PISSN: 00192805     EISSN: 13652567     Source Type: Journal    
DOI: 10.1111/j.1365-2567.2011.03443.x     Document Type: Article

References (32)

1. Seeliger S, Derian CK, Vergnolle N et al. Proinflammatory role of proteinase-activated receptor-2 in humans and mice during cutaneous inflammation in vivo. FASEB J 2003; 17:1871-85.
2. Shpacovitch V, Feld M, Hollenberg MD, Luger TA, Steinhoff M. Role of protease-activated receptors in inflammatory responses, innate and adaptive immunity. J Leukoc Biol 2008; 83:1309-22.
3. Ossovskaya VS, Bunnett NW. Protease-activated receptors: contribution to physiology and disease. Physiol Rev 2004; 84:579-621.
4. Shpacovitch V, Feld M, Bunnett NW, Steinhoff M. Protease-activated receptors: novel PARtners in innate immunity. Trends Immunol 2007; 28:541-50.
5. Corteling R, Bonneau O, Ferretti S, Ferretti M, Trifilieff A. Differential DNA synthesis in response to activation of protease-activated receptors on cultured guinea-pig tracheal smooth muscle cells. Naunyn Schmiedebergs Arch Pharmacol 2003; 368:10-6.
6. Hollenberg MD. Physiology and pathophysiology of proteinase-activated receptors (PARs): proteinases as hormone-like signal messengers: PARs and more. J Pharmacol Sci 2005; 97:8-13.
7. Tsanev R, Ivanov I. Immune interferon: properties and clinical applications. In: Hollinger MA, ed. Pharmacology and Toxicology Series. Boca Raton, FL: CRC Press LLC, 2002.
8. Feld M, Shpacovitch VM, Ehrhardt C, Kerkhoff C, Hollenberg MD, Vergnolle N, Ludwig S, Steinhoff M. Agonists of proteinase-activated receptor-2 enhance IFN-γ-inducible effects on human monocytes: role in influenza a infection. J Immunol 2008; 180:6903-10.
9. Khoufache K, LeBouder F, Morello E et al. Protective role for protease-activated receptor-2 against influenza virus pathogenesis via an IFN-γ-dependent pathway. J Immunol 2009; 182:7795-802.
10. Shpacovitch VM, Varga G, Strey A et al. Agonists of proteinase-activated receptor-2 modulate human neutrophil cytokine secretion, expression of cell adhesion molecules, and migration within 3-D collagen lattices. J Leukoc Biol 2004; 76:388-98.
11. Serbina NV, Jia T, Hohl TM, Pamer EG. Monocyte-mediated defense against microbial pathogens. Annu Rev Immunol 2008; 26:421-52.
12. Melgarejo E, Medina MA, Sanchez-Jimenez F, Urdiales JL. Monocyte chemoattractant protein-1: a key mediator in inflammatory processes. Int J Biochem Cell Biol 2009; 41:998-1001.
13. Yoshimura T, Takahashi M. IFN-γ-mediated survival enables human neutrophils to produce MCP-1/CCL2 in response to activation by TLR ligands. J Immunol 2007; 179:1942-9.
14. Amano H, Morimoto K, Senba M et al. Essential contribution of monocyte chemoattractant protein-1/C-C chemokine ligand-2 to resolution and repair processes in acute bacterial pneumonia. J Immunol 2004; 172:398-409.
15. Yamamoto T. Pathogenic role of CCL2/MCP-1 in scleroderma. Front Biosci 2008; 13:2686-95.
16. Shpacovitch VM, Seeliger S, Huber-Lang M et al. Agonists of proteinase-activated receptor-2 affect transendothelial migration and apoptosis of human neutrophils. Exp Dermatol 2007; 16:799-806.
17. Zwadlo G, Brocker EB, Von Bassewitz DB, Feige U, Sorg C. A monoclonal antibody to a differentiation antigen present on mature human macrophages and absent from monocytes. J Immunol 1985; 134:1487-92.
18. Essin K, Salanova B, Kettritz R et al. Large-conductance calcium-activated potassium channel activity is absent in human and mouse neutrophils and is not required for innate immunity. Am J Physiol Cell Physiol 2007; 293:C45-54.
19. Hampton MB, Winterbourn CC. Methods for quantifying phagocytosis and bacterial killing by human neutrophils. J Immunol Methods 1999; 232:15-22.
20. Perticarari S, Presani G, Banfi E. A new flow cytometric assay for the evaluation of phagocytosis and the oxidative burst in whole blood. J Immunol Methods 1994; 170:117-24.
21. Van Amersfoort ES, Van Strijp JA. Evaluation of a flow cytometric fluorescence quenching assay of phagocytosis of sensitized sheep erythrocytes by polymorphonuclear leukocytes. Cytometry 1994; 17:294-301.
22. Horsburgh MJ, Aish JL, White IJ, Shaw L, Lithgow JK, Foster SJ. SigmaB modulates virulence determinant expression and stress resistance: characterization of a functional rsbU strain derived from Staphylococcus aureus 8325-4. J Bacteriol 2002; 184:5457-67.
23. Ehrchen J, Sindrilaru A, Grabbe S, Schonlau F, Schlesiger C, Sorg C, Scharffetter-Kochanek K, Sunderkotter C. Senescent BALB/c mice are able to develop resistance to Leishmania major infection. Infect Immun 2004; 72:5106-14.
24. Moraes TJ, Martin R, Plumb JD et al. Role of PAR2 in murine pulmonary pseudomonal infection. Am J Physiol Lung Cell Mol Physiol 2008; 294:L368-77.
25. Ellis TN, Beaman BL. Interferon-γ activation of polymorphonuclear neutrophil function. Immunology 2004; 112:2-12.
26. Fernandez-Boyanapalli R, McPhillips KA, Frasch SC et al. Impaired phagocytosis of apoptotic cells by macrophages in chronic granulomatous disease is reversed by IFN-γ in a nitric oxide-dependent manner. J Immunol 2010; 185:4030-41.
27. Shpacovitch VM, Brzoska T, Buddenkotte J et al. Agonists of proteinase-activated receptor 2 induce cytokine release and activation of nuclear transcription factor kappaB in human dermal microvascular endothelial cells. J Invest Dermatol 2002; 118:380-5.
28. Burysek L, Syrovets T, Simmet T. The serine protease plasmin triggers expression of MCP-1 and CD40 in human primary monocytes via activation of p38 MAPK and janus kinase (JAK)/STAT signaling pathways. J Biol Chem 2002; 277:33509-17.
29. Harvey EJ, Li N, Ramji DP. Critical role for casein kinase 2 and phosphoinositide-3-kinase in the interferon-γ-induced expression of monocyte chemoattractant protein-1 and other key genes implicated in atherosclerosis. Arterioscler Thromb Vasc Biol 2007; 27:806-12.
30. Platanias LC. Mechanisms of type-I- and type-II-interferon-mediated signalling. Nat Rev Immunol 2005; 5:375-86.
31. Van der Merwe JQ, Moreau F, MacNaughton WK. Protease-activated receptor-2 stimulates intestinal epithelial chloride transport through activation of PLC and selective PKC isoforms. Am J Physiol Gastrointest Liver Physiol 2009; 296:G1258-66.
32. Uddin S, Sassano A, Deb DK et al. Protein kinase C-delta (PKC-δ) is activated by type I interferons and mediates phosphorylation of Stat1 on serine 727. J Biol Chem 2002; 277:14408-16.